Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.00017 | 1 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.003 | 1 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.00054 | 1 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.0036 | 1 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |